Work

Prospective, Single-blind, pilot trial of AbobotulinumtoxinA (AboA) in oromandibular dystonia (OMD) (P3.017)

Year: 2017

Type: article

Study design: Clinical Trial

Source: Neurology

DOI: 10.1212/wnl.88.16_supplement.p3.017

Authors: Stewart Factor, Michael Silver, John Hanfelt, Elaine Sperin, Laura Scorr, Alan Freeman, H. Jinnah

Institution: Emory University

Language: English

Topic: Botulinum Toxin and Related Neurological Disorders

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4389446219

FWCI:

Cites:

Cited by:

Related to: 10